A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Abroad (travel likely)RecruitingPHASE1
Conditions
Advanced or Metastatic Solid Tumors · Triple Negative Breast Cancer (TNBC) · HR+ Breast Cancer · Colon Cancer · Gastric Cancer · Hepatecellular Carcinoma · NSCLC (Advanced Non-small Cell Lung Cancer) · Mesothelioma · Pancreatic Carcinoma Metastatic · Hormone Refractory Prostate Cancer · Soft Tissue Sarcomas
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
SCRI at HCA HealthONE, Denver, Colorado, United States
Contact: Principal Investigator (Gerald Falchook, MD)The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Timothy Yap, MBBS, PhD)NEXT Oncology, San Antonio, Texas, United States
Contact: Principal Investigator (Ildefonso Rodriguez Rivera, MD)